Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
Sep. 15, 2025 Dry eyes are far more common than previously believed, with over half of adults in the US and Europe experiencing symptoms, yet most remain undiagnosed for years. The large-scale NESTS ...
Psoriasis is an autoimmune disease in which the skin becomes inflamed, producing red, flaky areas. It affects 1-2% of the population and is thought to be caused by misguided T cell attacks on the skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback